Norway· NO-ID_28484FC8-072D-4BE3-87D5-D319517D39C3

Paricalcitol-ratiopharm

A paricalcitol product containing paricalcitol, registered in Norway by Ratiopharm. The same ATC class is registered in 12 of our 19 countries.

ATC H05BX02

Checked against FEST (Norway) on August 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about paricalcitolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Paricalcitol is registered in 12 of 19 countries.

Countries holding a registration under ATC H05BX02 (paricalcitol), each read from that country’s own register.

This record: Norway, from FEST (Norway)
7 of them publish a price we can compare per daily dose

Search paricalcitol products by name

Paricalcitol · ATC H05BX02

12 / 19 countries

Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paricalcitol costs, country by country.

Normalised to the WHO defined daily dose (2 mcg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Paricalcitol · price per daily dose (2 mcg)

USD · FX 28 Sept 2026

CH Switzerland$11.31

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)

Active substance: Paricalcitol
Manufacturer: Ratiopharm
Country: Norway (NO)
ATC code: H05BX02
ATC class: Paricalcitol
Defined daily dose: 2 mcg, O
Reimbursed: Not published by this register
Source register: FEST (Norway)
Last checked: August 28, 2026

Packs & prices · 2

no_merkevare_id
ID_28484FC8-072D-4BE3-87D5-D319517D39C3
no_varenummer
228377
30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

285 interactions on record for paricalcitol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check paricalcitol against other medicines How interaction checks work

Paricalcitol · interactions on record

285 records

11 severe
108 moderate
166 info

Most severe, free to view

SucralfateA02BX02severe
ErgocalciferolA11CC01severe
DihydrotachysterolA11CC02severe
CalcitriolA11CC04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paricalcitol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paricalcitol products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Paricalcitol Accord, Zemplar
Bulgaria · Тевапаривит
Cyprus · Rextol
Czechia · Paricalcitol Accord, Paricalcitol Agmed
Germany · Paricalcitol Accord, Paricalcitol Hexal
Denmark · Paricalcitol Pharmathen
Spain · Paricalcitol Accord, Paricalcitol Accordpharma
Finland · Paricalcitol Accord, Paricalcitol Alternova
United Kingdom (Northern Ireland) · Zemplar
Greece · Aricitol, Panozin
Croatia · Parkol, Zemplar
Hungary · Paricalcitol Fresenius, Paricalcitol Onkogen
Ireland · Paricalcitol Pinewood Laboratories, Zemplar
Italy · Paracalcitolo Mylan, Paracalcitolo Sandoz
Luxembourg · Porontazin
Netherlands · Paricalcitol Accord, Paricalcitol Heaton
Poland · Paricalcitol Fresenius
Portugal · Paricalcitol Accord, Paricalcitol Altan
Romania · Paricalcitol, Rextol
Sweden · Paricalcitol Accord, Paricalcitol Alternova
Slovenia · Zemplar
Slovakia · Paricalcitol Heaton, Zemplar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/42530b63-1f96-4220-844e-455de10232f3
GET /v1/drugs/42530b63-1f96-4220-844e-455de10232f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsel, myk",
  "source": "fest",
  "status": "A",
  "atc_name": "Parikalsitol",
  "merkevare_id": "ID_28484FC8-072D-4BE3-87D5-D319517D39C3",
  "name_form_strength": "Paricalcitol-ratiopharm kaps 1 mikrog",
  "prescription_group": "C"
}

API reference MCP server Plans

See everything about paricalcitol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console